Literature DB >> 24167216

Unusual venous thrombosis in a 35-year-old man.

Ami Schattner.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24167216      PMCID： PMC3883824          DOI： 10.1503/cmaj.130006

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  18 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Utility of clinical examination in the diagnosis of emergency department patients admitted to the department of medicine of an academic hospital.

Authors:  Liza Paley; Taiba Zornitzki; Joel Cohen; Joshua Friedman; Natalia Kozak; Ami Schattner
Journal:  Arch Intern Med       Date:  2011-08-08

Review 3.  Risk assessment for recurrent venous thrombosis.

Authors:  Paul Alexander Kyrle; Frits R Rosendaal; Sabine Eichinger
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

Review 4.  Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.

Authors:  Ayalew Tefferi
Journal:  Am J Hematol       Date:  2012-03       Impact factor: 10.047

5.  Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial.

Authors:  A Piccioli; A W A Lensing; M H Prins; A Falanga; G L Scannapieco; M Ieran; M Cigolini; G B Ambrosio; M Monreal; A Girolami; P Prandoni
Journal:  J Thromb Haemost       Date:  2004-06       Impact factor: 5.824

Review 6.  Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?

Authors:  Marc Carrier; Grégoire Le Gal; Philip S Wells; Dean Fergusson; Tim Ramsay; Marc A Rodger
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

Review 7.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

Review 8.  Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

Authors:  Jodi B Segal; Daniel J Brotman; Alejandro J Necochea; Ashkan Emadi; Lipika Samal; Lisa M Wilson; Matthew T Crim; Eric B Bass
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

9.  Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.

Authors:  Willem M Lijfering; Jan-Leendert P Brouwer; Nic J G M Veeger; Ivan Bank; Michiel Coppens; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

Review 10.  The JAK2 V617F mutation and thrombosis.

Authors:  S K Austin; J R Lambert
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998
View more
  1 in total

1.  Unusual venous thrombosis.

Authors:  James D Douketis; Marc Carrier; Mark A Crowther
Journal:  CMAJ       Date:  2014-06-10       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.